Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology

Acta Pharmaceutica

Volumn 59, Issue 1, 2009, Pages 15-30

  Kumar, Pramod ^a   Singh, Sanjay ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Extended release; In vitro in vivo correlation; Osmotic pressure; Swellable polymer; Tramadol

Indexed keywords

CELLULOSE ACETATE; CONTIN; MACROGOL 400; MAGNESIUM STEARATE; PLASTICIZER; POLYMER; POVIDONE; TALC; TRAMADOL; TRAMAZAC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED DRUG RELEASE; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG FORMULATION; DRUG HALF LIFE; DRUG STABILITY; EXCIPIENT COMPATIBILITY; EXTENDED RELEASE FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSMOTIC PRESSURE;

EID: 62949129885     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0010-2     Document Type: Article

References (24)

1. nd ed., Marcel Dekker, New York 1987, pp. 373-374.
2. R. K. Verma, B. Mishra and S. Garg, Osmotically controlled oral drug delivery, Drug Dev. Ind. Pharm. 26 (2000) 695-708; DOI: 10.1081/DDC-100101287.
3. M. Speers and C. Bonnano, Economic Aspects of Controlled Drug Delivery, in Encyclopedia of Controlled Drug Delivery (Ed. E. Mathiowitz), Wiley, New York 1999, pp. 341-347.
4. R. K. Verma, D. M. Krishna and S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Rel. 79 (2002) 7-27; DOI: 10.1016/j.conrel.2003.09.009.
5. F. Theeuwes, Elementary osmotic pump, J. Pharm. Sci. 64 (1975) 1987-1991; DOI: 10.1002/jps.2600641218.
6. P. Kumar, S. Singh, P. S. Rajinikanth and B. Mishra, An overview of osmotic pressure controlled release formulation, J. Pharm. Res. 5 (2006) 34-45.
7. P. Kumar and B. Mishra, An overview of recent patents on oral osmotic drug delivery systems, Recent Patents on Drug. Del. Form. 1 (2007) 236-255; DOI: 10.2174/187221107782331638.
8. S. A. Schug, Tramadol in acute pain, Acute Pain 5 (2003) 1-3; DOI: 10.1016/S1366-0071(03) 00028-7.
9. C. Mattia and F. Coluzzi, Once-daily tramadol in rheumatological pain, Expert. Opin. Pharmacother. 7 (2006) 1811-1815; DOI: 10.1517/14656566.7.13.1811.
10. S. B. Tiwari, K. Murthy, M. R. Pai, P. R. Mehta and P. S. Choudhary, Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system, AAPPS Pharm. Sci. Tech. 4 (2003) 1-6.
11. P. Kumar, S. Singh and B. Mishra, Gastroretentive drug delivery system of ranitidine hydrochloride based on osmotic technology: development and evaluation, Curr. Drug Del. 5 (2008) 332-342; DOI: 10.2174/156720108785914943.
12. J. Shokri, P. Ahmedi, P. Rashidi, M. Shahsavri, A. R. Siahboomi and A. Nokhodchi, Swellable elementary osmotic pump (SEOP): An effective device for delivery of poorly water soluble drugs, Eur. J. Pharm. Biopharm. 68 (2008) 289-297; DOI: 10.1016/j.ejpb.200706.006.
13. United States Pharmacopoeia 30, National Formulary vol. 1, USP Convention, Rockville 2007.
14. C. Aguzzi, M. C. Bonferoni, M. R. Osorio, F. S. Rossi, F. Ferrari and C. Caramella, Influence of complex solubility on formulations based on lambda carrageenan and basic drugs, AAPPS Pharm. Sci. Tech. 3 (2002) 1-7.
15. M. R. Rouini, Y. H. Ardakani, F. Soltani, H. Y. Aboul-Enein and A. Foroumadi, Development and validation of rapid HPLC method for simultaneous determination of tramadol and its metabolites in human plasma, J. Chromatogr. B. 830 (2006) 207-211; DOI: 10.1016/j.jchromb.2005.10.039.
16. A. Kucuk, Y. Kadioglu and F. Celebi, Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction, J. Chrom. B. 816 (2005) 203-208; DOI: 10.1016/j.jchromb. 2004.11.031.
17. P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
18. B. Mishra, B. V. Bakde, P. N. Singh and P. Kumar, Development and in-vitro evaluation of oral sustained release formulation of tramadol hydrochloride, Acta Pharm. Sci. 48 (2006) 153-166.
19. X. Li, W. Pan, S. Nie and L. Wu, Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe, J. Control. Rel. 96 (2004) 359-367; DOI: 10.1016/j/jconrel.2004.01.026.
20. N. Sinchaipanid, S. Pongwai, P. Limsuwan and A. Mitrevej, Design of salbutamol EOP tablets from pharmacokinetic parameters, Pharm. Dev. Technol. 8 (2003) 135-142; DOI: 10.1081/PDT-120018479.
21. F. Musshoff and B. Madea, Fatality due to ingestion of tramadol alone, Forensic Sci. Int. 116 (2001) 197-199; DOI: 10.1016/s0379-0738(00) 00374-1.
22. A. M. Razaghi and J. B. Schwartz, Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water swellable polymer, Drug Dev. Ind. Pharm. 28 (2002) 631-639; DOI: 10.1018.DDC-120003855.
23. A. M. Razaghi and J. B. Schwartz, Release of cyclobenzaprine hydrochloride from osmotically rupturable tablets, Drug. Dev. Ind. Pharm. 28 (2002) 695-701; DOI: 10.1081/DDC-120003861.
24. ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, EMEA, London 2003.